# Maria Stendahl

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/maria-stendahl/

## Facts

| Field | Value |
| --- | --- |
| Citations | 3,144 |
| Field | Dialysis and Renal Disease Management |
| h-index | 27 |
| i10-index | 36 |
| Last Known Institution | Region Jönköpings län |
| OpenAlex ID | https://openalex.org/A5038261777 |
| Works | 61 |

## Researcher papers

- [Serum potassium and adverse outcomes across the range of kidney function: a CKD Prognosis Consortium meta-analysis](https://scholariq.org/papers/serum-potassium-and-adverse-outcomes-across-the-range-of-kidney-function-a-ckd/)
- [Change in albuminuria and subsequent risk of end-stage kidney disease: an individual participant-level consortium meta-analysis of observational studies](https://scholariq.org/papers/change-in-albuminuria-and-subsequent-risk-of-end-stage-kidney-disease-an/)
- [CKD Progression and Mortality Among Men and Women: A Nationwide Study in Sweden](https://scholariq.org/papers/ckd-progression-and-mortality-among-men-and-women-a-nationwide-study-in-sweden/)
- [Measures of chronic kidney disease and risk of incident peripheral artery disease: a collaborative meta-analysis of individual participant data](https://scholariq.org/papers/measures-of-chronic-kidney-disease-and-risk-of-incident-peripheral-artery/)
- [Cyclin D1 overexpression is a negative predictive factor for tamoxifen response in postmenopausal breast cancer patients](https://scholariq.org/papers/cyclin-d1-overexpression-is-a-negative-predictive-factor-for-tamoxifen-response/)
- [High Progesterone Receptor Expression Correlates to the Effect of Adjuvant Tamoxifen in Premenopausal Breast Cancer Patients](https://scholariq.org/papers/high-progesterone-receptor-expression-correlates-to-the-effect-of-adjuvant/)
- [Adverse Effect of Adjuvant Tamoxifen in Premenopausal Breast Cancer with <i>Cyclin D1</i> Gene Amplification](https://scholariq.org/papers/adverse-effect-of-adjuvant-tamoxifen-in-premenopausal-breast-cancer-with-i/)
- [The ERA-EDTA Registry Annual Report 2017](https://scholariq.org/papers/the-era-edta-registry-annual-report-2017/)
- [The ERA Registry Annual Report 2019: summary and age comparisons](https://scholariq.org/papers/the-era-registry-annual-report-2019-summary-and-age-comparisons/)
- [The ERA-EDTA Registry Annual Report 2018: a summary](https://scholariq.org/papers/the-era-edta-registry-annual-report-2018-a-summary/)
- [The Swedish Renal Registry: a nationwide registry for chronic kidney disease of all stages](https://scholariq.org/papers/the-swedish-renal-registry-a-nationwide-registry-for-chronic-kidney-disease-of/)

## Researcher topics

- [Dialysis and Renal Disease Management](https://scholariq.org/topics/dialysis-and-renal-disease-management/)
- [Chronic Kidney Disease and Diabetes](https://scholariq.org/topics/chronic-kidney-disease-and-diabetes/)
- [Renal Transplantation Outcomes and Treatments](https://scholariq.org/topics/renal-transplantation-outcomes-and-treatments/)
- [COVID-19 Clinical Research Studies](https://scholariq.org/topics/covid-19-clinical-research-studies/)
- [Acute Kidney Injury Research](https://scholariq.org/topics/acute-kidney-injury-research/)

## Researcher university

- [Region Jönköpings län](https://scholariq.org/institutions/region-jonkopings-lan/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.